The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-(-)-9-(4-aminopiperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid ID: ALA1215659
Cas Number: 1152314-49-2
PubChem CID: 46829291
Max Phase: Preclinical
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H]1COc2c(N3CCN(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
Standard InChI: InChI=1S/C17H19FN4O4/c1-9-8-26-16-13-10(15(23)11(17(24)25)7-22(9)13)6-12(18)14(16)20-2-4-21(19)5-3-20/h6-7,9H,2-5,8,19H2,1H3,(H,24,25)/t9-/m0/s1
Standard InChI Key: ICQVSZFWVUBYSI-VIFPVBQESA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
2.0750 -3.2083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7917 -1.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3583 -2.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6458 -3.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3583 -1.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7917 -2.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0792 -1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0708 -2.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6417 -4.0333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0708 -1.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6458 -1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7833 -3.2083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5083 -1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2167 -4.0333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0750 -4.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0792 -0.7292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3625 -4.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5000 -2.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7833 -4.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5000 -4.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2167 -3.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5083 -0.7292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7833 -1.5542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.9333 -4.4458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2208 -1.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7917 -4.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 2 0
3 1 1 0
4 3 1 0
5 3 2 0
6 1 1 0
7 5 1 0
8 4 2 0
9 4 1 0
10 11 2 0
11 5 1 0
12 8 1 0
13 2 1 0
14 20 1 0
15 1 1 0
16 7 2 0
17 15 1 0
18 12 1 0
19 12 1 0
20 19 1 0
21 18 1 0
22 13 2 0
23 10 1 0
24 14 1 0
25 13 1 0
15 26 1 1
17 9 1 0
7 2 1 0
8 10 1 0
14 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.36Molecular Weight (Monoisotopic): 362.1390AlogP: 0.79#Rotatable Bonds: 2Polar Surface Area: 101.03Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.12CX Basic pKa: 5.73CX LogP: -0.24CX LogD: -1.51Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.14
References 1. Rossi F, Valentina C, Garavaglia S, Sathyasaikumar KV, Schwarcz R, Kojima S, Okuwaki K, Ono S, Kajii Y, Rizzi M.. (2010) Crystal structure-based selective targeting of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement., 53 (15): [PMID:20684605 ] [10.1021/jm100464k ] 2. Dounay AB, Tuttle JB, Verhoest PR.. (2015) Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway., 58 (22): [PMID:26207924 ] [10.1021/acs.jmedchem.5b00461 ]